Abstract:Recent genome-wide association studies (GWAS) with metabolomics data linked genetic variation in the human genome to differences in individual metabolite levels. A strong relevance of this metabolic individuality for biomedical and pharmaceutical research has been reported. However, a considerable amount of the molecules currently quantified by modern metabolomics techniques are chemically unidentified. The identification of these "unknown metabolites" is still a demanding and intricate task, limiting their usability as functional markers of metabolic processes. As a consequence, previous GWAS largely ignored unknown metabolites as metabolic traits for the analysis. Here we present a systems-level approach that combines genome-wide association analysis and Gaussian graphical modeling with metabolomics to predict the identity of the unknown metabolites. We apply our method to original data of 517 metabolic traits, of which 225 are unknowns, and genotyping information on 655,658 genetic variants, measured in 1,768 human blood samples. We report previously undescribed genotype-metabotype associations for six distinct gene loci (SLC22A2, COMT, CYP3A5, CYP2C18, GBA3, UGT3A1) and one locus not related to any known gene (rs12413935). Overlaying the inferred genetic associations, metabolic networks, and knowledge-based pathway information, we derive testable hypotheses on the biochemical identities of 106 unknown metabolites. As a proof of principle, we experimentally confirm nine concrete predictions. We demonstrate the benefit of our method for the functional interpretation of previous metabolomics biomarker studies on liver detoxification, hypertension, and insulin resistance. Our approach is generic in nature and can be directly transferred to metabolomics data from different experimental platforms.

Metabolomics in the field of biomedical research

Statistical Methods for the Analysis of High-Throughput Metabolomics Data

Computational Approaches for Systems Metabolomics

Metabolomics analysis for biomarker discovery: advances and challenges

(Pre)Clinical Metabolomics Analysis

Metabolomics in clinical and forensic toxicology, sports anti‐doping and veterinary residues

Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information.

Advances in high throughput LC/MS based metabolomics: A review

The Potential of Metabolomics in Biomedical Applications

Recent Trends in Strategies and Methodologies for Metabonomics

Metabonomics: its potential as a tool in toxicology for safety assessment and data integration

Metabolomics as a Truly Translational Tool for Precision Medicine

Current trends in analytical methodologies and experimental strategies for metabonomics

Current Trends and Innovations in Bioanalytical Techniques of Metabolomics

Pharmacometabonomics: data processing and statistical analysis

Metabolomics: Towards Understanding Host-Microbe Interactions.

Guide to Metabolomics Analysis: A Bioinformatics Workflow

Metabolomics:A Key Player in Systems Biomedicine

Metabolomics meets lipidomics: Assessing the small molecule component of metabolism

Network-based strategies in metabolomics data analysis and interpretation: from molecular networking to biological interpretation

Progress and perspective in application of bio-informatics to metabolomics and metabonomics